Jean Paul Fermand
- Molecular Biology top 5%
- Hematology top 2%
- Genetics top 2%
- Nephrology top 1%
- Oncology top 10%
- Co-authors
- Pierre RoncoPhilippe MoreauGiampaolo MerliniVaishali SanchorawalaAlan SolomonOrhan SezerRodney H. FalkRay Comenzo
- Topics
- Multiple Myeloma Research and Treatments (20 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers)Cancer Treatment and Pharmacology (6 papers)
- Cited by
- NephrologyHematologyGenetics
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Jean Paul Fermand
35 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Molecular Biology 1.5k
- Hematology 603
- Genetics 433
- Nephrology 415
- Oncology 357
Countries citing papers authored by Jean Paul Fermand
This map shows the geographic impact of Jean Paul Fermand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Paul Fermand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Paul Fermand more than expected).
Fields of papers citing papers by Jean Paul Fermand
This network shows the impact of papers produced by Jean Paul Fermand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Paul Fermand. The network helps show where Jean Paul Fermand may publish in the future.
Co-authorship network of co-authors of Jean Paul Fermand
This figure shows the co-authorship network connecting the top 25 collaborators of Jean Paul Fermand. A scholar is included among the top collaborators of Jean Paul Fermand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Paul Fermand. Jean Paul Fermand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 69 | |
| 2 | 40 | |
| 3 | 16 | |
| 4 | 26 | |
| 5 | 39 | |
| 6 | 1 | |
| 7 | 37 | |
| 8 | 13 | |
| 9 | 29 | |
| 10 | 10 | |
| 11 | 6 | |
| 12 | 46 | |
| 13 | 24 | |
| 14 | Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosisbreakdown → | 992 |
| 15 | 62 | |
| 16 | 99 | |
| 17 | 15 | |
| 18 | 28 | |
| 19 | 24 | |
| 20 | 13 |
About Jean Paul Fermand
Jean Paul Fermand is a scholar working on Hematology, Genetics and Oncology, having authored 36 papers that have together received 1.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (20 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Nephrology (415 citations), Hematology (603 citations) and Genetics (433 citations). Jean Paul Fermand has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Pierre Ronco, Philippe Moreau, Giampaolo Merlini, Vaishali Sanchorawala, Alan Solomon, Orhan Sezer, Rodney H. Falk, Ray Comenzo, Bouke P. C. Hazenberg and Philip N. Hawkins. Their work appears in journals such as Journal of Clinical Oncology, Blood and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.